Lesley‐Ann Martin

5.9k citations

80 papers · 3.9k indexed · 2 hit papers · h-index 33

Oncology top 1%
Molecular Biology top 5%
Cancer Research top 1%
Genetics top 1%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Mitch Dowsett Stephen Johnston Sunil Pancholi Neill Patani Simak Ali Ricardo Ribas Ian Farmer Nicholas C. Turner
Topics: Estrogen and related hormone effects (42 papers)HER2/EGFR in Cancer Research (19 papers)Advanced Breast Cancer Therapies (17 papers)
Cited by: Cancer Research Oncology Genetics
Journals: Journal of Biological Chemistry Nature Communications Journal of Clinical Oncology
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Lesley‐Ann Martin

79 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer

2016 511 citations María Teresa Herrera-Abreu, Marta Palafox et al. Cancer Research profile →
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer

2015 416 citations Isaac García-Murillas, Rosalind Cutts et al. profile →

Peers

Countries citing papers authored by Lesley‐Ann Martin

Since Specialization

Citations

This map shows the geographic impact of Lesley‐Ann Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley‐Ann Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley‐Ann Martin more than expected).

Fields of papers citing papers by Lesley‐Ann Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley‐Ann Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley‐Ann Martin. The network helps show where Lesley‐Ann Martin may publish in the future.

Co-authorship network of co-authors of Lesley‐Ann Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley‐Ann Martin. A scholar is included among the top collaborators of Lesley‐Ann Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley‐Ann Martin. Lesley‐Ann Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers 2023 ·Cancer Research ·(unknown),Marjan Iravani,Rania El Botty,John Alexander,Laura Sourd,Ludivine Morisset,Pierre Painsec,(unknown),Joanna Nikitorowicz-Buniak,Sunil Pancholi,Syed Haider,Mitch Dowsett,Elisabetta Marangoni,Lesley‐Ann Martin,Clare M. Isacke	6
2	Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer 2022 ·npj Breast Cancer ·Sunil Pancholi,Nikiana Simigdala,Ricardo Ribas,Eugene F. Schuster,Mariana Ferreira Leal,Joanna Nikitorowicz-Buniak,(unknown),Teeru Bihani,Hitisha Patel,Stephen Johnston,Mitch Dowsett,Lesley‐Ann Martin	10
3	Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities 2020 ·Oncogene ·Sunil Pancholi,Ricardo Ribas,Nikiana Simigdala,Eugene F. Schuster,Joanna Nikitorowicz-Buniak,(unknown),Qiong Gao,Mariana Ferreira Leal,Amandeep Bhamra,(unknown),Ludivine Morisset,Élodie Montaudon,Laura Sourd,Martin Fitzpatrick,Maarten Altelaar,Stephen Johnston,Elisabetta Marangoni,Mitch Dowsett,Lesley‐Ann Martin	63
4	Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors 2019 ·Clinical Cancer Research ·Mariana Ferreira Leal,Ben P. Haynes,Eugene F. Schuster,Belinda Yeo,Maria Afentakis,Lila Zabaglo,Vera Martins,Richard Buus,Andrew Dodson,Maggie C.U. Cheang,Ian E. Smith,Lesley‐Ann Martin,Mitch Dowsett	13
5	De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy 2019 ·Autophagy ·Gabriela Andrejeva,Sharon Gowan,Gigin Lin,(unknown),(unknown),Harold G. Parkes,(unknown),Florence I. Raynaud,Yasmin J. Asad,Gema Vizcay‐Barrena,Joanna Nikitorowicz-Buniak,Melanie Valenti,Louise Howell,Roland A. Fleck,Lesley‐Ann Martin,Vladimir Kirkin,Martin O. Leach,Yuen‐Li Chung	76
6	Capture Hi-C identifies putative target genes at 33 breast cancer risk loci 2018 ·Nature Communications ·(unknown),Olivia C. Leavy,Nicola H. Dryden,Sarah Maguire,Nichola Johnson,Vita Fedele,Nikiana Simigdala,Lesley‐Ann Martin,Simon Andrews,Steven Wingett,Ioannis Assiotis,Kerry Fenwick,Ritika Chauhan,Alistair G. Rust,Nick Orr,Frank Dudbridge,Syed Haider,Olivia Fletcher	72
7	Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer 2018 ·Breast Cancer Research ·Ricardo Ribas,Sunil Pancholi,Aradhana Rani,Eugene F. Schuster,Stephanie K. Guest,Joanna Nikitorowicz-Buniak,Nikiana Simigdala,(unknown),Francesca Avogadri-Connors,Richard E. Cutler,Alshad S. Lalani,Mitch Dowsett,Stephen Johnston,Lesley‐Ann Martin	16
8	miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors 2016 ·Cancer Research ·Marina Bacci,Elisa Giannoni,Antony Fearns,Ricardo Ribas,Qiong Gao,Maria Letizia Taddei,Gianfranco Pintus,Mitch Dowsett,Clare M. Isacke,Lesley‐Ann Martin,Paola Chiarugi,Andrea Morandi	81
9	Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancerbreakdown → 2016 ·Cancer Research ·María Teresa Herrera-Abreu,Marta Palafox,Uzma Asghar,Martín A. Rivas,Rosalind Cutts,Isaac García-Murillas,Alex Pearson,Marta Guzmán,Olga Rodríguez,Judit Grueso,Meritxell Bellet,Javier Cortés,Richard Elliott,Sunil Pancholi,Christopher J. Lord,José Baselga,Mitch Dowsett,Lesley‐Ann Martin,Nicholas C. Turner,Violeta Serra	511
10	AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo 2015 ·Molecular Cancer Therapeutics ·Ricardo Ribas,Sunil Pancholi,Stephanie K. Guest,Elisabetta Marangoni,Qiong Gao,Aurélie Thuleau,Nikiana Simigdala,Urszula M. Polanska,(unknown),Aradhana Rani,Gianmaria Liccardi,Stephen Johnston,Barry R. Davies,Mitch Dowsett,Lesley‐Ann Martin	49
11	Effect of Aromatase Inhibition on Functional Gene Modules in Estrogen Receptor–Positive Breast Cancer and Their Relationship with Antiproliferative Response 2014 ·Clinical Cancer Research ·Qiong Gao,Neill Patani,Anita K. Dunbier,Zara Ghazoui,Marketa Zvelebil,Lesley‐Ann Martin,Mitch Dowsett	31
12	Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer 2014 ·Clinical Cancer Research ·Neill Patani,Anita K. Dunbier,H Anderson,Zara Ghazoui,Ricardo Ribas,Elizabeth J. Anderson,Qiong Gao,Roger A’Hern,Alan Mackay,Justin P.O. Lindemann,Robert Wellings,Jill Walker,Irene Kuter,Lesley‐Ann Martin,Mitch Dowsett	16
13	GDNF–RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors 2013 ·Cancer Research ·Andrea Morandi,Lesley‐Ann Martin,Qiong Gao,Sunil Pancholi,Alan Mackay,David Robertson,Marketa Zvelebil,Mitch Dowsett,Iván Plaza-Menacho,Clare M. Isacke	83
14	Biomarkers for the clinical management of breast cancer: International perspective 2012 ·International Journal of Cancer ·Neill Patani,Lesley‐Ann Martin,Mitch Dowsett	143
15	Biological Evidence for Dual Antiangiogenic-Antiaromatase Activity of the VEGFR Inhibitor PTK787/ZK222584 In vivo 2010 ·Clinical Cancer Research ·Susana Banerjee,Roger A’Hern,Simone Detre,Amanda Littlewood‐Evans,Dean B. Evans,Mitch Dowsett,Lesley‐Ann Martin	14
16	Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer with Acquired Endocrine Resistance 2010 ·Clinical Cancer Research ·Alexandra Léary,Suzanne Drury,Simone Detre,Sunil Pancholi,Anne E. Lykkesfeldt,Lesley‐Ann Martin,Mitch Dowsett,Stephen Johnston	70
17	The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ZK222584 Inhibits Aromatase 2009 ·Cancer Research ·Susana Banerjee,Marketa Zvelebil,Pascal Furet,(unknown),Dean B. Evans,Mitch Dowsett,Lesley‐Ann Martin	21
18	The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo 2007 ·Molecular Cancer Therapeutics ·Lesley‐Ann Martin,Julia E. Head,Sunil Pancholi,Janine Salter,Emma M. Quinn,Simone Detre,Stan B. Kaye,Angela Howes,Mitch Dowsett,Stephen Johnston	37
19	Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. 2003 ·PubMed ·Giles Davies,Janine Salter,Margaret Hills,Lesley‐Ann Martin,Nigel Sacks,Mitch Dowsett	111
20	Integration of Signal Transduction Inhibitors with Endocrine Therapy 2003 ·Clinical Cancer Research ·Stephen Johnston,Julia E. Head,Sunil Pancholi,Simone Detre,Lesley‐Ann Martin,Ian E. Smith,Mitch Dowsett	3

About Lesley‐Ann Martin

Lesley‐Ann Martin is a scholar working on Genetics, Oncology and Cancer Research, having authored 80 papers that have together received 3.9k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (42 papers), HER2/EGFR in Cancer Research (19 papers) and Advanced Breast Cancer Therapies (17 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.9k citations) and Genetics (1.2k citations). Lesley‐Ann Martin has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Mitch Dowsett, Stephen Johnston, Sunil Pancholi, Neill Patani, Simak Ali, Ricardo Ribas, Ian Farmer, Nicholas C. Turner, Isaac García-Murillas and Giles Davies. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact